E-LIB Suche - Ergebnisse für: Keating, Amy K

1

Risk Factors for Hematotoxicity Following Tisagenlecleucel ..:

McNerney, Kevin Owen ; Fabrizio, Vanessa A. ; Talleur, Aimee C....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S219-S220 , 2024

Link: https://doi.org/10.1016/..

2

Effects of Total Body Irradiation on Hematopoietic Cell Tra..:

Takahashi, Takuto ; Lake, Alexander J. ; Wachter, Franziska...
Transplantation and Cellular Therapy. 30 (2024) 8 - p. 812.e1-812.e11 , 2024

Link: https://doi.org/10.1016/..

3

Pathobiological signatures of dysbiotic lung injury in pedi..:

Zinter, Matt S. ; Dvorak, Christopher C. ; Mayday, Madeline Y....
Nature Medicine. 30 (2024) 7 - p. 1982-1993 , 2024

Link: https://doi.org/10.1038/..

4

Establishing Costs for Commercial Chimeric Antigen Receptor..:

Satwani, Prakash ; Chao, Karen ; Lopez-Garcia, Maria...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S224-S225 , 2024

Link: https://doi.org/10.1016/..

5

Antiviral cellular therapy for enhancing T-cell reconstitut..:

Keller, Michael D. ; Hanley, Patrick J. ; Chi, Yueh-Yun...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

6

HLH-like toxicities predict poor survival after the use of ..:

McNerney, Kevin O. ; Si Lim, Stephanie J. ; Ishikawa, Kyle...
Blood Advances. 7 (2023) 12 - p. 2758-2771 , 2023

Link: https://doi.org/10.1182/..

7

Higher doses of tisagenlecleucel are associated with improv..:

Stefanski, Heather E. ; Eaton, Anne ; Baggott, Christina...
Blood Advances. 7 (2023) 4 - p. 541-548 , 2023

Link: https://doi.org/10.1182/..

8

Access to Chimeric Antigen Receptor T Cell Clinical Trials ..:

Hall, Anurekha G. ; Winestone, Lena E. ; Sullivan, Erin M....
Transplantation and Cellular Therapy. 29 (2023) 6 - p. 356.e1-356.e7 , 2023

Link: https://doi.org/10.1016/..

9

Improved Relapse-Free Survival (RFS) for Pediatric and Youn..:

John, Samuel ; Heim, Michael ; Curran, Kevin J....
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S37-S38 , 2023

Link: https://doi.org/10.1016/..

10

High Disease Burden and Severe Neutropenia Predict HLH Toxi..:

McNerney, Kevin O. ; Lim, Stephanie Si ; Miller, Alexandra...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S202-S203 , 2023

Link: https://doi.org/10.1016/..

11

Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic..:

Lin, Chenyu ; Schwarzbach, Aurelie ; Sanz, Jaime...
Transplantation and Cellular Therapy. 29 (2023) 5 - p. 338.e1-338.e6 , 2023

Link: https://doi.org/10.1016/..

12

Excellent Relapse-Free and Overall Survival in Pre-HCT Next..:

Abdel-Azim, Hisham ; Quigg, Troy C. ; Malvar, Jemily...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S94-S96 , 2023

Link: https://doi.org/10.1016/..

13

Relapse Risk for B-ALL Patients By Pre-Hematopoietic Cell T..:

Quigg, Troy C. ; Skiles, Jodi L. ; Keating, Amy K....
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S130-S131 , 2022

Link: https://doi.org/10.1016/..

14

CT-314 Multicenter Long-Term Follow Up of Allogeneic Hemato..:

Lin, Chenyu ; Schwarzbach, Aurelie ; Montesinos, Pau...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S442 , 2022

Link: https://doi.org/10.1016/..

15

Time to transplantation and pediatric acute myeloid leukemi..:

Murphy, Lindsey A. ; Miller, Kristen ; Winters, Amanda C....
Bone Marrow Transplantation. 58 (2022) 3 - p. 343-345 , 2022

Link: https://doi.org/10.1038/..